Publicaciones en colaboración con investigadores/as de Oslo University Hospital (12)

2023

  1. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)

    Journal of Nutrition, Health and Aging

2022

  1. Human milk fatty acid composition and its association with maternal blood and adipose tissue fatty acid content in a cohort of women from Europe

    European Journal of Nutrition, Vol. 61, Núm. 4, pp. 2167-2182

  2. Mode of Neonatal Delivery Influences the Nutrient Composition of Human Milk: Results From a Multicenter European Cohort of Lactating Women

    Frontiers in Nutrition, Vol. 9

  3. The Dietary Inflammatory Index Is Associated with Subclinical Mastitis in Lactating European Women

    Nutrients, Vol. 14, Núm. 22

2021

  1. Analysis of dietary patterns and nutritional adequacy in lactating women: a multicentre European cohort (ATLAS study)

    Journal of Nutritional Science, Vol. 10

  2. Human milk oligosaccharides, infant growth, and adiposity over the first 4 months of lactation

    Pediatric Research, Vol. 90, Núm. 3, pp. 684-693

  3. International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives

    ERJ Open Research, Vol. 7, Núm. 3

2020

  1. Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis

    European Respiratory Journal, Vol. 55, Núm. 2

  2. Subclinical mastitis in a European multicenter cohort: Prevalence, impact on human milk (HM) composition, and association with infant HM intake and growth

    Nutrients, Vol. 12, Núm. 1

2019

  1. Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

    Journal of Nutrition, Health and Aging, Vol. 21, Núm. 1, pp. 92-104

2000

  1. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial

    Human Reproduction, Vol. 15, Núm. 7, pp. 1490-1498